Expression of the stem cell marker nestin in peripheral blood of patients with melanoma

被引:25
|
作者
Fusi, A. [1 ]
Ochsenreither, S. [1 ]
Busse, A. [1 ]
Rietz, A. [1 ]
Keilholz, U. [1 ]
机构
[1] Charite, Dept Hematol & Med Oncol, D-12200 Berlin, Germany
关键词
circulating tumour cell; melanoma; nestin; reverse transcription-polymerase chain reaction; tumour markers; INTERMEDIATE-FILAMENT NESTIN; CIRCULATING TUMOR-CELLS; BRAIN-TUMORS; PROGNOSIS; PODOCYTES; GENE;
D O I
10.1111/j.1365-2133.2010.09779.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P>Background There is continued interest in markers indicative of circulating melanoma cells. Nestin is a neuroepithelial intermediate filament protein that was found to be expressed in melanoma and in various cancer stem cells. Objectives We investigated expression of nestin in peripheral blood of patients with melanoma. Methods We analysed nestin expression by flow cytometry and by quantitative reverse transcription-polymerase chain reaction both in tissues (n = 23) and in blood samples (n = 102) from patients with American Joint Committee on Cancer stage III-IV melanoma. Forty-six negative controls were also added. Results Flow cytometry did not reveal nestin-expressing cells in peripheral blood of healthy volunteers. In patients with melanoma, however, nestin protein was expressed in a proportion of melanoma cells enriched from peripheral blood by immunomagnetic sorting. In melanoma tissue samples a significant correlation was found between mRNAs coding for nestin and tyrosinase (P = 0 center dot 001) and melan-A (P = 0 center dot 002), whereas in blood a significant correlation was observed only for tyrosinase (P = 0 center dot 015), but not for melan-A (P = 0 center dot 53). Nestin expression was higher in stage IV patients compared with stage III/IV with no evidence of disease, in patients with high tumour burden, and was positively correlated to expression of tyrosinase and melan-A. Conclusions Nestin was found to be an additional marker of interest for circulating melanoma cells. Prospective studies should investigate its potential added informative value in comparison with markers already in use for melanoma cell detection.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [41] Peripheral blood stem cell collection in elderly patients
    Adrian Tempescul
    Jean-Christophe Ianotto
    Elisabeth Hardy
    Francoise Quivoron
    Ljubomir Petrov
    Christian Berthou
    Annals of Hematology, 2010, 89 : 317 - 321
  • [42] PCR-detection of occult melanoma cells in peripheral blood stem cell harvests of patients with metastatic malignant melanoma.
    Schrader, A
    ProbstKepper, M
    Buer, J
    Grosse, J
    Hertenstein, B
    Ganser, A
    Atzpodien, J
    BLOOD, 1997, 90 (10) : 2405 - 2405
  • [43] False tumor marker surge evoked by peripheral blood stem cell transplantation
    Inoue, Masaharu
    Koga, Fumitaka
    Kawakami, Satoru
    Numao, Noboru
    Sakura, Mizuaki
    Kobayashi, Tsuyoshi
    Kihara, Kazunori
    ONCOLOGIST, 2008, 13 (05): : 526 - 529
  • [44] RT-PCR tyrosinase expression in the peripheral blood of melanoma patients
    Quaglino, P
    Savoia, P
    Osella-Abate, S
    Bernengo, MG
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (05) : 727 - 741
  • [45] Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer
    Padin-Iruegas, Maria-Elena
    Herranz-Carnero, Michel
    Aguin-Losada, Santiago
    Brozos-Vazquez, Elena
    Anido-Herranz, U.
    Antunez-Lopez, Jose-Ramon
    Ruibal-Morell, Alvaro
    Lopez-Lopez, Rafael
    ONCOLOGY REPORTS, 2013, 29 (06) : 2467 - 2472
  • [46] Evaluation of nestin expression in melanoma, basal cell carcinoma and basosquamous carcinoma
    Mokhtari, Mojgan
    Safari, Negar
    IMMUNOPATHOLOGIA PERSA, 2024, 10 (02):
  • [47] Electronic Volume, Aldehyde Dehydrogenase, and Stem Cell Marker Expression in Cells from Human Peripheral Blood Apheresis Samples
    Sharma, Siddharth
    Shariatmadar, Sherry
    Krishan, Awtar
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (02) : 123 - 129
  • [48] Nestin expression in osteocytes after allogeneic stem cell transplant
    Koerber, R. - M.
    Teichmann, L. L.
    Schneider, R. K.
    Guetgemann, I
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 115 - 115
  • [49] VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation
    Autore, Francesco
    Mannina, Daniele
    Lessi, Federica
    Galli, Eugenio
    Oliva, Stefania
    Derudas, Daniele
    Giannotta, Claudia
    Crippa, Claudia
    Mancuso, Katia
    Marcatti, Magda
    Innocenti, Idanna
    Mazza, Rita
    Bramanti, Stefania
    Laurenti, Luca
    HEMATOLOGICAL ONCOLOGY, 2025, 43 (02)
  • [50] The stem cell marker nestin regulates growth, invasion and stemness of malignant melanomas
    Akiyama, Michiko
    Kawahara, Kiyoko
    Matsuda, Yoko
    Takayama, Ryoko
    Yamamoto, Tetsushi
    Ishiwata, Toshiyuki
    Kawana, Seiji
    Naito, Zenya
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S14 - S14